Callan JMB gets Nasdaq bid-price deficiency notice
Callan JMB Inc. has received a Nasdaq notice that its common stock no longer meets the $1.00 minimum bid price requirement, based on 30 consecutive business days below that level.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Callan JMB Inc. has received a Nasdaq notice that its common stock no longer meets the $1.00 minimum bid price requirement, based on 30 consecutive business days below that level. The stock continues to trade on the Nasdaq Capital Market under the symbol CJMB.
The company has an initial 180-day compliance period, until December 28, 2026, to regain compliance by achieving at least $1.00 per share for a minimum of ten consecutive business days, or longer if Nasdaq requires. If still noncompliant, a second 180-day period may be available, potentially involving a reverse stock split.
If compliance is not regained within the allowed periods, Nasdaq may initiate delisting, which the company could appeal to a Nasdaq Hearings Panel. Callan JMB states it will actively monitor its share price and consider options, including a reverse split, but there is no assurance it will maintain its listing.
Insights
Nasdaq bid-price deficiency creates real delisting risk if not cured.
Callan JMB Inc. has fallen below Nasdaq’s $1.00 minimum bid price standard for 30 consecutive business days. This triggers a formal deficiency notice but does not immediately remove the shares from the Nasdaq Capital Market.
The company has an initial 180-day window to lift the closing bid to at least $1.00 for ten consecutive business days, with Nasdaq able to extend that requirement up to 20 days. A second 180-day period is possible if other listing standards, including market value of publicly held shares, are met.
If the price does not recover, Callan JMB may need structural actions, such as a reverse stock split, to regain compliance. Failure to remedy within the available periods could lead to a delisting determination and appeal before a Nasdaq Hearings Panel, which would materially affect where and how the stock trades.
8-K Event Classification
Key Figures
Key Terms
Minimum Bid Price Requirement regulatory
Nasdaq Listing Rule 5550(a)(2) regulatory
reverse stock split financial
Nasdaq Hearings Panel regulatory
forward-looking statements regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What Nasdaq notice did Callan JMB Inc. (CJMB) receive?
Does the Nasdaq notice immediately delist Callan JMB (CJMB) stock?
How long does Callan JMB (CJMB) have to regain Nasdaq bid-price compliance?
What steps might Callan JMB (CJMB) take to meet Nasdaq’s minimum bid price?
What happens if Callan JMB (CJMB) cannot meet Nasdaq’s bid-price rule?
Will Callan JMB (CJMB) definitely remain listed on Nasdaq?
AI-generated analysis. How Rhea-AI works. Not financial advice.